The Case For Parallel Processing In Clinical Trial Start-Up
By Kimberly Ponder, Director, Project Optimization, Avacare Clinical Research Network

In clinical research, a linear path is often a slow one and can create avoidable bottlenecks that delay First Patient In and inflate budgets. For Sponsors and CROs, these delays are more than administrative hurdles; they represent significant strategic risks that can derail a trial's momentum. Parallel processing can transform a study start-up from a series of hurdles into a synchronized sprint. By initiating contracts, budgets, regulatory submissions, and site training concurrently, agile sites can compress activation timelines by weeks.
Stop letting outdated processes stall your innovation. Read the full piece to discover the essential infrastructure, technology, and mindset required to execute parallel workflows. You will also learn the critical questions to ask potential site partners to ensure they are operationally equipped to turn your start-up strategy into a commercial edge.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.